Skip to main content
. Author manuscript; available in PMC: 2017 Mar 2.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):390–398. doi: 10.1097/QAI.0000000000001274

Table 2. Patient outcomes after becoming ART eligible by ART status.

Day 7 Month 1 Month 3 Month 6 Month 9 Month 12 Month 24
ART status n (%) n (%) n (%) n (%) n (%) n (%) n (%)
On ART N=319 N=934 N=1,179 N=1,248 N=1,281 N=1,302 N=1,332
Retained 312 97.81 902 96.57 1,104 93.64 1,124 90.06 1,127 87.98 1,125 86.41 1,074 80.63
Dead 2 0.63 11 1.18 31 2.63 56 4.49 63 4.92 72 5.53 84 6.31
LTFU 5 1.57 19 2.03 38 3.22 56 4.49 70 5.46 82 6.30 133 9.98
Transferred out 0 0.00 2 0.21 6 0.51 12 0.96 21 1.64 23 1.77 41 3.08

Not on ART N=1,180 N=565 N=320 N=251 N=218 N=197 N=167
Retained 1,121 95.0 472 83.54 210 65.63 133 52.99 98 44.95 75 38.07 39 23.35
Dead 0 0.00 16 2.83 22 6.88 25 9.96 25 11.47 25 12.69 25 14.97
LTFU 57 4.83 75 13.27 83 25.94 88 35.06 90 41.28 92 46.70 98 58.68
Transferred out 2 0.17 2 0.35 5 1.56 5 1.99 5 2.29 5 2.54 5 2.99

ART: Antiretroviral therapy. LTFU: Loss to follow-up. N: Total. n: Sub-total. %: Column percentages.